Fong S, Chen P P, Gilbertson T A, Fox R I, Vaughan J H, Carson D A
J Immunol. 1985 Sep;135(3):1955-60.
The monoclonal antibody (MoAb) 17.109 recognizes a cross-reactive idiotype (CRI) associated with the light chains of Waldenstrom's macroglobulins with rheumatoid factor (RF) activity. The MoAb also reacts with a proportion of IgM-RF molecules from the sera of rheumatoid arthritis and primary Sjogren's syndrome patients, and from the sera of seropositive normal human subjects. In the present experiments, we used affinity chromatography to purify the 17.109 CRI-positive immunoglobulin from serum and have analyzed the isolated material by Western blotting. The purified 17.109 CRI-positive material from the sera of rheumatoid arthritis patients, Sjogren's syndrome patients, and normal subjects contained exclusively kappa light chains, and had demonstrated RF activity. In every case the 17.109 CRI-positive isolates reacted with antibodies against synthetic peptides corresponding to both the conserved second and third complementarity-determining regions (CDR) of the monoclonal kappa IgM-RF paraprotein Sie. The binding was inhibited specifically by the free peptides in solution. The antipeptide antibodies did not react appreciably with unfractionated human immunoglobulin. The data establish that the 17.109 CRI-positive immunoglobulin from diverse human sera have similar or identical second and third light chain CDR. These results suggest i) that the MoAb 17.109 identifies the protein product of a single or a very few V kappa genes, ii) that the ability to make kappa light chains with the 17.109-associated variable region is widespread in the human population, and iii) that the 17.109-defined kappa variable region segment is associated with IgM-RF autoantibodies.
单克隆抗体(MoAb)17.109识别一种与具有类风湿因子(RF)活性的瓦尔登斯特伦巨球蛋白轻链相关的交叉反应独特型(CRI)。该单克隆抗体还与类风湿性关节炎和原发性干燥综合征患者血清以及血清反应阳性的正常人类受试者血清中的一部分IgM-RF分子发生反应。在本实验中,我们使用亲和层析从血清中纯化17.109 CRI阳性免疫球蛋白,并通过蛋白质印迹法分析分离出的物质。从类风湿性关节炎患者、干燥综合征患者和正常受试者血清中纯化的17.109 CRI阳性物质仅含有κ轻链,并已证明具有RF活性。在每种情况下,17.109 CRI阳性分离物都与针对对应于单克隆κ IgM-RF副蛋白Sie保守的第二和第三互补决定区(CDR)的合成肽的抗体发生反应。溶液中的游离肽可特异性抑制这种结合。抗肽抗体与未分级的人免疫球蛋白没有明显反应。这些数据表明,来自不同人类血清的17.109 CRI阳性免疫球蛋白具有相似或相同的第二和第三轻链CDR。这些结果表明:i)单克隆抗体17.109识别单个或极少数Vκ基因的蛋白质产物;ii)具有与17.109相关可变区的κ轻链的产生能力在人群中广泛存在;iii)17.109定义的κ可变区片段与IgM-RF自身抗体相关。